Evidence map›Paper›PMID 27535091›Full record

ArticleToxicology and applied pharmacology2016

Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.

Natalia Kovalova, Maria Manzan, Robert Crawford, Norbert Kaminski

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Natalia KovalovaDepartment of Pharmacology and Toxicology, Michigan State University, Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: kovalova@msu.edu.
Maria ManzanInstitute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: ale.manzan@gmail.com.
Robert CrawfordInstitute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: crawfo28@msu.edu.
Norbert KaminskiDepartment of Pharmacology and Toxicology, Michigan State University, Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: kamins11@msu.edu.
Michigan State University · US

Funding

VOLATILE ORGANIC CONTAMINANTS--QUANTIFYING THEIR MOVEMENT IN THE UNSATURATED ZONEP42ES004911 · NIEHS · MICHIGAN STATE UNIVERSITY · PI Timothy R. Zacharewski · 1989 to 2026
$64.9M
TOXIC EFFECTS OF TCDD ON B CELLSR01ES002520 · NIEHS · VIRGINIA COMMONWEALTH UNIVERSITY · PI KAMINSKI, NORBERT E · 1986 to 2016
$4.2M
NIEHS NIH HHS P42 ES004911NIEHS NIH HHS R01 ES002520
6 · The paper itself

Abstract

Previous studies have demonstrated that most of the intraspecies variation in sensitivity to the toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), including suppression of antibody responses, in murine models is due to single nucleotide polymorphisms (SNPs) within the aryl hydrocarbon receptor (AhR) gene. The underlying reason for variation in sensitivity to TCDD-induced suppression of IgM responses among humans is not well understood, but is thought, in part, to be a result of different polymorphic forms of the AhR expressed by different individuals. In this study, the functional properties of six (P517S, R554K, V570I, V570I+P517S, R554K+V570I and P517S+R554K+V570I) human AhR variants were examined in the human B cell line, SKW 6.4. TCDD-induced Cyp1B1 and Cyp1A2 mRNA expression levels and Cyp1B1-regulated reporter gene activity, used for comparative purposes, were markedly lower in SKW cells containing the R554K SNP than in SKW-AHR(+) (control AhR) cells. Furthermore, all AhR variants were able to mediate TCDD-induced suppression of the IgM response; however, a combined P517S+R554K+V570I variant partially reduced sensitivity to TCDD-mediated suppression of IgM secretion. Collectively, our findings show that the R554K human AhR SNP alone altered sensitivity of human B cells to TCDD-mediated induction of Cyp1B1 and Cyp1A2. By contrast, attenuation of TCDD-induced IgM suppression required a combination of all three SNPs P517S, R554K, and V570I.

Indexed as

Polymorphism, Single NucleotideAnimalsB-LymphocytesCytochrome P-450 CYP1A2Cytochrome P-450 CYP1B1Enzyme InductionFemaleHumansImmunoglobulin MMiceMice, Inbred C57BLPolychlorinated DibenzodioxinsRatsRats, Sprague-DawleyReceptors, Aryl HydrocarbonCYP1A2 protein, humanCYP1B1 protein, humanCytochrome P-450 CYP1A2Cytochrome P-450 CYP1B1Immunoglobulin MPolychlorinated DibenzodioxinsReceptors, Aryl Hydrocarbon2,3,7,8-Tetrachlorodibenzo-p-dioxinB cellsSingle nucleotide polymorphisms

Identifiers

PMID27535091
PMCPMC5035641
OpenAlexW2510310761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.